RecruitingPhase 3NCT06033599

Motivational Interviewing and Mindfulness-Oriented Recovery Enhancement

Motivational Interviewing (MI) and Mindfulness-Oriented Recovery Enhancement (MORE) for Tobacco Dependence and Other Drug Use in Methadone Treatment


Sponsor

Rutgers, The State University of New Jersey

Enrollment

420 participants

Start Date

Sep 5, 2023

Study Type

INTERVENTIONAL

Conditions

Summary

The purpose of this study is to 1) examine barriers and facilitators to implementation of MI and MORE for polysubstance use and evaluate strategies for optimizing training, fidelity, and clinic uptake, and 2) evaluate patient outcomes related to the effectiveness of MORE decreasing opioid, tobacco, and other drug use.


Eligibility

Min Age: 18 Years

Inclusion Criteria3

  • English-speaking
  • Age ≥18
  • Currently on methadone; and 4) currently smoke cigarettes.

Exclusion Criteria7

  • Severe cognitive impairment (score \>23 on Mini Mental Status Exam) or psychosis (positive SCID Psychotic Screen)
  • Suicidal risk (score ≥7 on Suicidal Behaviors Questionnaire)
  • Inability to attend or fully participate in intervention sessions or assessments
  • Previous formal mindfulness training (e.g., MBSR, MBRP) or MORE (from the R21 or R33
  • Currently taking smoking cessation pharmacotherapy or participating in smoking cessation counseling
  • Any contraindications for NRT
  • Currently or soon planning to be pregnant or breastfeeding.

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

OTHERMORE and MI and NRT

Eight group Mindfulness Oriented Recovery Enhancement sessions and one motivational interviewing session and nicotine replacement therapy.

OTHERMORE and No MI and NRT

Eight group Mindfulness Oriented Recovery Enhancement sessions and nicotine replacement therapy.

OTHERSupport Group and MI and NRT

Eight group support group sessions and one motivational interviewing session and nicotine replacement therapy.

OTHERSupport Group and No MI and NRT

Eight group support group sessions and and nicotine replacement therapy.


Locations(2)

Rutgers Robert Wood Johnson Medical School

New Brunswick, New Jersey, United States

University of Utah

Salt Lake City, Utah, United States

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT06033599


Related Trials